Related Experiment Videos
[Recurrent pneumococcal meningitis after splenectomy]
M Gerwig1, A Wittkämper, U Liebetrau
1Neurologische Klinik, Kliniken der Stadt Köln.
Der Nervenarzt
|October 1, 1994
Summary
Splenectomy for Werlhof's disease can lead to recurrent pneumococcal meningitis, particularly from vaccine-excluded type 13. Careful consideration of splenectomy necessity and post-operative infection risk is crucial for patients.
Area of Science:
- Immunology
- Infectious Diseases
- Hematology
Background:
- Werlhof's disease, also known as immune thrombocytopenic purpura, is an autoimmune disorder.
- Splenectomy is a potential treatment option for refractory cases of immune thrombocytopenic purpura.
- Post-splenectomy infections, especially encapsulated bacteria, represent a significant clinical concern.
Observation:
- A patient with Werlhof's disease underwent splenectomy.
- Following splenectomy, the patient developed recurrent pneumococcal meningitis.
- The causative agent was identified as Streptococcus pneumoniae capsular type 13.
Findings:
- Pneumococcal type 13 is not covered by the standard 23-valent pneumococcal polysaccharide vaccine.
- Splenectomy significantly increases the risk of severe infections, including meningitis.
- Recurrent infections highlight the importance of vaccine-preventable pathogens post-splenectomy.
Implications:
- The decision for splenectomy in autoimmune diseases requires careful risk-benefit assessment.
- Patients undergoing splenectomy must be thoroughly counseled on the heightened risk of infection.
- Prophylactic and immediate medical treatment for infections post-splenectomy is essential, considering non-vaccine serotypes.